2MJ-20216-00548
2 vaccinations
3 coded responses
3 check-ins
3 free-text entries
3 call cases
- Sex
- Male
- Age at first dose
- 46-50
- ZIP prefix
- 445 / OH
- Registered
- 2021-12-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-09
Dose 1 — Janssen/Johnson & Johnson
-
2021-12-27
Dose 2 — Pfizer-BioNTech
-
2021-12-30
Registered in v-safe
-
2021-12-30
Survey response — days 1–6 daily, dose 2MedDRA: Deep vein thrombosis — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: I had a DVT in my left leg 11/6/21 with no known precipitating factors. It was quite extensive including common femoral, anterior/posterior tibial and saphenous veins.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-30
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
-
2021-12-31
Survey response — days 1–6 daily, dose 2MedDRA: Deep vein thrombosis, Peripheral swelling, Pruritus, Skin discolouration, Superficial vein thrombosis, Venous thrombosis limb — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Systemic reaction (other): 11/6/21 - DVT in lower left leg with no underlying conditions or medical explanations. extensive clot in femoral vein, exterior and posterior tibial veins and saphenous vein. · Healthcare visit (other): currently taking eliquis and still have swelling, itching and discoloration of lower left legMedDRA releases: 2024-11 · check-in free text available
-
2021-12-31
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
-
2022-01-02
Survey response — days 1–6 daily, dose 2MedDRA: Deep vein thrombosis — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: 11/6/21 - significant DVT lower left leg, femoral, exterior/interior tibial and saphenous veins. Cause not linked to surgery, known infection, trauma or family historyMedDRA releases: 2024-11 · check-in free text available
-
2022-01-02
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2022-01-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-09 | Janssen/Johnson & Johnson | No |
| 2 | 2021-12-27 | Pfizer-BioNTech | No |
Call center
3 call center cases
3 unsuccessful
Free text
Release 10 — days 1–6 daily, dose 2
Systemic reaction (other): I had a DVT in my left leg 11/6/21 with no known precipitating factors. It was quite extensive including common femoral, anterior/posterior tibial and saphenous veins.
Systemic reaction (other): 11/6/21 - DVT in lower left leg with no underlying conditions or medical explanations. extensive clot in femoral vein, exterior and posterior tibial veins and saphenous vein.
Healthcare visit (other): currently taking eliquis and still have swelling, itching and discoloration of lower left leg
Systemic reaction (other): 11/6/21 - significant DVT lower left leg, femoral, exterior/interior tibial and saphenous veins. Cause not linked to surgery, known infection, trauma or family history
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Peripheral swelling | · | · | ✓ |
| HCVO | Pruritus | · | · | ✓ |
| HCVO | Skin discolouration | · | · | ✓ |
| SRO | Deep vein thrombosis | · | · | ✓ |
| SRO | Superficial vein thrombosis | · | · | ✓ |
| SRO | Venous thrombosis limb | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release